InvestorsHub Logo

Whalatane

01/19/23 3:08 PM

#16176 RE: cervelo #16175

Actually I'm interested in your thoughts
Whats your opinion on the current studies with Anifrolumab , Obinutuzmab and Secukinumab and their applications for LN ......or do U think Big Pharma is ignoring those developments ?

https://www.astrazeneca-us.com/media/press-releases/2022/first-patients-dosed-in-iris-phase-iii-trial-evaluating-anifrolumab-in-lupus-nephritis.html

https://www.clinicaltrials.gov/ct2/show/NCT04181762
as example

Kiwi